9WD3
Crystal structure of HPK1 kinase in complex with a potent and selective inhibitor with in vivo efficacy
This is a non-PDB format compatible entry.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRF BEAMLINE BL17U1 |
| Synchrotron site | SSRF |
| Beamline | BL17U1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2022-07-05 |
| Detector | ADSC QUANTUM 315r |
| Wavelength(s) | 1.0 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 116.618, 99.603, 116.998 |
| Unit cell angles | 90.00, 90.44, 90.00 |
Refinement procedure
| Resolution | 22.780 - 3.220 |
| R-factor | 0.2547 |
| Rwork | 0.252 |
| R-free | 0.30810 |
| Structure solution method | MOLECULAR REPLACEMENT |
| RMSD bond length | 0.013 |
| RMSD bond angle | 1.237 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHENIX (1.17.1_3660) |
| Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 22.780 | 3.400 |
| High resolution limit [Å] | 3.220 | 3.220 |
| Rmerge | 0.117 | 0.475 |
| Number of reflections | 40416 | 7227 |
| <I/σ(I)> | 6.4 | 2.6 |
| Completeness [%] | 92.0 | 99 |
| Redundancy | 3 | |
| CC(1/2) | 0.984 | 0.797 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 6.9 | 291 | 0.1 M HEPES pH 6.9, 8% w/v Polyethylene glycol 6,000, 5% v/v (+/-)-2-Methyl-2,4-pentanediol, 10 mM GSH/GSSG |






